By rejecting patent applications, developing countries have kept down the costs of much-needed medications.
Gleevec, a leukemia drug, costs $70,000 per year in the United States, but only costs $2,500 in India. Why does that drug cost so much more in the U.S.?
Continue reading… “Why does chemotherapy cost $70k in the U.S., but only costs $2.5k in India?”